Open Demo Account
Home / Market Update / CureVac Planning to Produce 300-400 Million Vaccine Doses in 2021

CureVac Planning to Produce 300-400 Million Vaccine Doses in 2021

Adel 12 November, 2020 6:40 pm Market Update

German biotech CureVac’s CEO, Franz-Werner Haas, said on Thursday that they are planning to produce 300-400 million doses of their coronavirus vaccine in 2021, as reported by Reuters.

Tags

Check Also

Liquidity Crunch: Traders Face a Shifting Market in June 2025

Markets in June 2025 face a liquidity squeeze that’s reshaping how traders operate. U.S. Treasury …

This site contains information and opinions for the purpose of providing only general information and can not be relied upon. The information and opinions contained in this Site shall in no way constitute an offer or solicitation to buy, sell or subscribe to any investment product. Users of this site shall bear any risks arising from the use of any information, opinion, program, service or material. Noor Trends reserves the right to make any change to the Site, the information, opinions, materials, products, programs, services or prices (if any) at any time without notice.
All copyrights reserved Noor Trends